Strengthening Rare Disease Support in Malaysia with VALENS Nutrition

12 March 2026

KUALA LUMPUR: Malaysia’s observance of National Rare Disease Day and the launch of the National Policy for Rare Diseases mark a significant step forward in providing long-term, sustainable care for individuals with rare, complex genetic conditions. This development has garnered increasing attention from both public and private stakeholders across the healthcare sector.

A key element of ongoing care for certain rare genetic metabolic disorders is specialised nutrition, which is often a therapeutic necessity rather than a matter of dietary preference. For individuals diagnosed with inborn errors of metabolism (IEM), lifelong strict dietary management is essential. These patients require precisely calibrated nutritional formulations to prevent metabolic complications, as their bodies may struggle to process specific nutrients effectively.

Securing reliable access to specialised nutrition is therefore critical for building a more resilient and effective care system for rare disease patients.

When Nutrition Becomes Critical Support

Unlike regular dietary support, specialised nutrition for rare metabolic disorders is tailored to meet exact biochemical needs. Even minor disruptions in supply can significantly impact disease management, especially for paediatric patients whose growth and neurological development depend on precise dietary regulation.

Dr Ngu Lock Hock, Clinical Genetics Consultant and Head of the Genetics Department at Hospital Kuala Lumpur, highlights Malaysia’s historical dependence on imported specialised nutrition products.

"Many metabolic formulas and dietary substitutes have been sourced from overseas. While they offer necessary clinical support, reliance on imports exposes us to supply vulnerabilities and higher costs," he explained.

Global factors such as currency fluctuations, transportation challenges, manufacturing issues, and geopolitical tensions can all lead to supply disruptions, further complicating long-term care and increasing financial burdens for families and healthcare providers.

"In metabolic care, consistency is vital. Any interruption, be it delays or affordability issues, causes stress for caregivers and poses clinical risks for patients," Dr Ngu added.

Addressing Supply Vulnerability through Local Production

Malaysia’s heavy reliance on imported specialised metabolic nutrition mirrors international patterns, where production is often concentrated among a few global manufacturers. Recent global supply chain disruptions have underscored the need for stronger domestic resilience, especially in critical healthcare components.

While discussions often focus on pharmaceutical supply security, specialised nutrition for rare metabolic conditions has received comparatively less attention. The newly launched National Policy for Rare Diseases provides a strategic framework to strengthen Malaysia’s healthcare ecosystem, including enhancing access to essential services and long-term support.

Within this context, developing local production capacity for specialised metabolic nutrition is a vital step. Initiatives are underway among Malaysian healthcare solutions providers to produce tailored nutritional products domestically. Among these is VALENS, a specialised nutrition brand developed by Pharm-D Health Science, a homegrown pharmaceutical and consumer health company, which manufactures protein-free nutritional products for metabolic disorders.

These local efforts aim to complement existing imported options, reducing dependence on foreign supply chains and enabling faster response times, more stable distribution, and closer collaboration between manufacturers and healthcare providers.

Industry experts note that building domestic capability does not replace international innovation but creates a more balanced and resilient healthcare environment for patients with rare diseases.

Patients received locally produced specialised nutrition hampers during the National Rare Disease Day 2026 Opening Ceremony at Hospital Tunku Azizah, officiated by Health Minister Datuk Seri Dr Dzulkefly Ahmad on February 4, 2026.

Supporting Long-Term Sustainability

For families managing rare metabolic disorders, care extends beyond clinical settings into daily routines. Parents and caregivers meticulously monitor dietary intake, calculate nutrient allowances, and adhere strictly to prescribed nutritional regimens.

Reliable access to specialised nutrition supports clinical stability and improves quality of life. As Malaysia progresses with its rare disease agenda, ensuring continuity in supply aligns with broader goals of healthcare sustainability and system resilience.

Dr Ngu emphasised that collaboration among policymakers, clinicians, patient advocates, and industry stakeholders is essential.

"Policy, clinical expertise, advocacy, and responsible industry participation must work together to improve rare disease care. Building sustainable access to specialised nutrition is a shared responsibility," he stated.

Towards a More Resilient Rare Disease Ecosystem

Experts agree that healthcare resilience must encompass more than pharmaceuticals; it should include critical components like specialised nutrition. Developing local production capacity is a practical and necessary step to strengthen this aspect of care.

As Malaysia’s local capabilities grow alongside international partnerships, the country’s rare disease healthcare system will benefit from greater stability, responsiveness, and preparedness, ultimately supporting patients and families across the nation.